New hope for kids with relapsing kidney disease
NCT ID NCT07091175
Summary
This trial is testing if a drug called dupilumab can help children with a severe, recurring kidney condition called nephrotic syndrome. The main goal is to see if dupilumab injections can keep the disease in remission longer and allow kids to safely reduce their steroid medication. Researchers will compare dupilumab to a placebo in 66 children over 6 months to see if it works and is safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEPHROTIC SYNDROME IN CHILDREN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
KK Women's and Children's Hospital
RECRUITINGSingapore, Singapore, 229899, Singapore
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
National University Hospital
RECRUITINGSingapore, Singapore, 119228, Singapore
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.